Published 2022 | Version v1
Journal article

A 3D deep learning model to predict the diagnosis of dementia with lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET [translational research]

  • 1. Center for Applied Intelligent Systems Research (CAISR), Halmstad University, Halmstad (Sweden)
  • 2. Department of Clinical Physiology, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping (Sweden)
  • 3. National Cheng Kung University in Tainan, Tainan (China)
  • 4. Department of Nuclear Medicine, Medical Imaging Area, Hospital Universitari i Politècnic La Fe, Valencia (Spain)
  • 5. Servicio de Medicina Nuclear, Hospital de La Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona (Spain)
  • 6. Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa (Italy)
  • 7. Department of Diagnostic Radiology, Linköping University Hospital, Linköping (Sweden)
  • 8. Department of Medical Physics, Linköping University Hospital, Linköping (Sweden)
  • 9. National Institute of Nuclear Physics (INFN), Genoa section, Genoa (Italy)
  • 10. Department of Nuclear Medicine, University Hospital, LMU Munich, Munich (Germany)
  • 11. Department of Nuclear Medicine, Inselspital, University Hospital Bern, Bern (Switzerland)
  • 12. Biomedical Research Institute, Hasselt University, Hasselt (Belgium)
  • 13. Neurology Department, University Hospitals Leuven, Leuven (Belgium)
  • 14. Department of Neurosciences, Laboratory for Cognitive Neurology, Leuven, KU (Belgium)
  • 15. Department of Neurology, University Medical Centre, Ljubljana (Slovenia)
  • 16. Faculty of Medicine, University of Ljubljana, Ljubljana (Slovenia)
  • 17. Department of Clinical Neurosciences, Geneva University Hospitals, Geneva (Switzerland)
  • 18. LANVIE (Laboratoire de Neuroimagerie du Vieillissement), Department of Psychiatry, University Hospitals, Geneva (Switzerland)
  • 19. Department of Neurology, Alzheimer Center, Amsterdam (Netherlands)
  • 20. Department of Radiology & Nuclear Medicine, Amsterdam UMC, location VUmc, Amsterdam (Netherlands)
  • 21. Parkinson's Disease Rehabilitation Centre, FERB ONLUS – S. Isidoro Hospital, Trescore Balneario, BG (Italy)
  • 22. Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia (Italy)
  • 23. Department of Health Sciences, University of Genoa, Genoa (IT)
  • 24. Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa (IT)
  • 25. Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London (GB)
  • 26. Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger (NO)
  • 27. Clinical Neurology, IRCCS Ospedale Policlinico San Martino, Genoa (IT)
  • 28. Department of Neuroscience (DINOGMI), University of Genoa, Genoa (IT)
  • 29. Division of Nuclear Medicine and Molecular Imaging, University Hospitals of Geneva and NIMTLab, Faculty of Medicine, University of Geneva, Geneva (CH)
  • 30. Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping (SE)
  • 31. Department of Diagnostic Radiology, Linköping University Hospital, Linköping (SE)
  • 32. Department of Clinical Physiology, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping (SE)

Description

The purpose of this study is to develop and validate a 3D deep learning model that predicts the final clinical diagnosis of Alzheimer's disease (AD), dementia with Lewy bodies (DLB), mild cognitive impairment due to Alzheimer's disease (MCI-AD), and cognitively normal (CN) using fluorine 18 fluorodeoxyglucose PET (18F-FDG PET) and compare model's performance to that of multiple expert nuclear medicine physicians' readers. Retrospective 18F-FDG PET scans for AD, MCI-AD, and CN were collected from Alzheimer's disease neuroimaging initiative (556 patients from 2005 to 2020), and CN and DLB cases were from European DLB Consortium (201 patients from 2005 to 2018). The introduced 3D convolutional neural network was trained using 90% of the data and externally tested using 10% as well as comparison to human readers on the same independent test set. The model's performance was analyzed with sensitivity, specificity, precision, F1 score, receiver operating characteristic (ROC). The regional metabolic changes driving classification were visualized using uniform manifold approximation and projection (UMAP) and network attention. The proposed model achieved area under the ROC curve of 96.2% (95% confidence interval: 90.6-100) on predicting the final diagnosis of DLB in the independent test set, 96.4% (92.7-100) in AD, 71.4% (51.6-91.2) in MCI-AD, and 94.7% (90-99.5) in CN, which in ROC space outperformed human readers performance. The network attention depicted the posterior cingulate cortex is important for each neurodegenerative disease, and the UMAP visualization of the extracted features by the proposed model demonstrates the reality of development of the given disorders. Using only 18F-FDG PET of the brain, a 3D deep learning model could predict the final diagnosis of the most common neurodegenerative disorders which achieved a competitive performance compared to the human readers as well as their consensus.

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-021-05483-0

Additional details

Identifiers

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
49
Journal Issue
2
Journal Page Range
p. 563-584
ISSN
1619-7070
CODEN
EJNMA6